A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
NCT ID: NCT06052319
Last Updated: 2025-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
277 participants
OBSERVATIONAL
2023-11-29
2024-08-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TeleDiet Study: The Impact of Dietary Education and Counseling With a Smartphone Application on Secondary Prevention of Coronary Artery Disease
NCT05071495
Wearable Technology and a Virtual Lifestyle Program for Type 2 Diabetics
NCT04498819
RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients
NCT05961943
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology
NCT03167996
An E-health Intervention for Patients With Peripheral Artery Disease
NCT05029739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) or Both
Participants with CAD or PAD or both will be directed to download the Care4Today® (C4T) Connect CAD-PAD mobile application on iPhone or Android device to assess engagement and usefulness of C4T in disease management for 3 months. No study drug and other treatment(s) will be provided as a part of this study. All aspects of treatment and clinical management of participants will continue to be in accordance with local clinical practice and applicable local regulations, and at the discretion of the participating physician.
Care4Today® Connect CAD-PAD Mobile Application
Participants will not receive any drug intervention in this study. Participants will use Care 4Today® Connect CAD-PAD mobile application for 3 months. The study will assess participant engagement and usefulness.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Care4Today® Connect CAD-PAD Mobile Application
Participants will not receive any drug intervention in this study. Participants will use Care 4Today® Connect CAD-PAD mobile application for 3 months. The study will assess participant engagement and usefulness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Own an iPhone or Android mobile device
* Have an active email account
* Must sign a participation agreement or informed consent form (ICF) allowing data collection in accordance with local requirements
* Willing to download and use Care4Today (C4T) CAD-PAD application (app)
Exclusion Criteria
* Unable to read or write the language used for the C4T (English, or Spanish if Spanish version is available)
* Visual or hearing impairment or mental disability that would preclude independent app use
* Patients currently using the C4T app prior to the signing of ICF
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HCA Research Institute, LLC
UNKNOWN
Janssen Scientific Affairs, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janssen Scientific Affairs, LLC Clinical Trial
Role: STUDY_DIRECTOR
Janssen Scientific Affairs, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
HCA Florida Memorial Hospital
Jacksonville, Florida, United States
University of Florida Health Jacksonville
Jacksonville, Florida, United States
The Kansas City Heart Rhythm Institute
Overland Park, Kansas, United States
HCA Houston Healthcare Medical Center
Houston, Texas, United States
Rio Grande Regional Hospital
McAllen, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lakkireddy D, Angiolillo DJ, Charlton-Ouw K, Jefferson B, Peeran S, Bisharat M, Ortega-Paz L, Harxhi A, Kaul S, Michaud E, Juan S, Woods B, Damaraju CV, Fontana G, Bonaca MP. Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study). Clin Cardiol. 2024 Dec;47(12):e70039. doi: 10.1002/clc.70039.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NOPRODPEA0001
Identifier Type: OTHER
Identifier Source: secondary_id
NOPRODPEA0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.